Improving Urinary Continence and Quality of Life in Prostate Cancer Patients

Sponsor
Case Western Reserve University (Other)
Overall Status
Completed
CT.gov ID
NCT01365182
Collaborator
National Cancer Institute (NCI) (NIH)
279
3
65

Study Details

Study Description

Brief Summary

This intervention program combines biofeedback PFME with a telephone or support group intervention to treat persistent urinary incontinence (UI). The study's primary aims are to improve continence, quality of life, and mood through enhancing adherence to PFME and self-management of incontinence symptoms. The secondary aims are to examine the physiological effects and cost effectiveness of the proposed interventions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: BF+SUPPORT
  • Behavioral: BF+PHONE
Phase 3

Detailed Description

This is a randomized, controlled longitudinal study. Patients with early-stage prostate cancer and UI for more than six months were randomly assigned to one of three study arms: (1) biofeedback PFME plus a support group (BF+SUPPORT); (2) biofeedback PFME plus telephone (BF+PHONE); and (3) usual care (UC). The BF+SUPPORT and BF+PHONE participants learned PFME through computerized biofeedback. Thereafter, the BF+SUPPORT participants attended six group meetings and the BF+PHONE participants had six phone contacts every other week for three months. The UC participants did not receive biofeedback PFME or telephone/group intervention but continued receiving usual medical care. All subjects were assessed blind at baseline, 3 months (post intervention) and 6 months (follow-up). In addition, 49 moderately to severely incontinent patients were recruited from the three study groups to undergo urodynamic testing at baseline and 3 months for the evaluation of physiological changes. Data of the costs for the interventions and the participants' medical care were collected for a cost-effectiveness analysis.

Study Design

Study Type:
Interventional
Actual Enrollment :
279 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Dec 1, 2013
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Other: BF+SUPPORT

Behavioral: BF+SUPPORT
A session of biofeedback-assisted pelvic floor muscle exercises (PFME) plus 6 group sessions of the Problem-Solving Therapy (teaching self-management skills).

Other: BF+PHONE

Behavioral: BF+PHONE
A session of biofeedback-assisted pelvic floor muscle exercises (PFME) plus 6 telephone sessions of the Problem-Solving Therapy (teaching self-management skills).

No Intervention: Usual Care

Outcome Measures

Primary Outcome Measures

  1. Urinary incontinence [6 months]

    Frequency of daily leakage measured on 3-day diary Amount of leakage measured on 1-hour pad test

  2. Quality of Life (QOL) [6 months]

    The International Prostate Symptom Score (IPSS) University of California-Los Angeles Prostate Cancer Index (UCLA-PCI) Visual Analogue Scale (VAS) Health-related QOL: SF36 EQ-5D Index

  3. Mood [6 months]

    The Profile of Mood States (POMS): subscales of tension, depression and hostility.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Have been diagnosed with early stage (I-III) prostate cancer.

  2. Have completed cancer treatments six months prior.

  3. Presence of incontinence symptoms

Exclusion Criteria:
  1. Receiving hormonal treatment.

  2. Urinary tract infection or urinary retention.

  3. Cognitive impairment.

  4. Having an implant

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Case Western Reserve University
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Amy Zhang, Ph.D., Case Western Reserve University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amy Zhang, Associate Professor, Case Western Reserve University
ClinicalTrials.gov Identifier:
NCT01365182
Other Study ID Numbers:
  • CASE 14807
  • 1R01CA127493-01A2
First Posted:
Jun 3, 2011
Last Update Posted:
Feb 18, 2015
Last Verified:
Feb 1, 2015
Keywords provided by Amy Zhang, Associate Professor, Case Western Reserve University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 18, 2015